Advanced inhalation technologies
Breath Therapeutics has raised €44M across 1 funding round from 3 investors, most recently a Series A round in Mar 2017. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Series A | €44M |
| Gilde Healthcare,GIMV,Sofinnova Partners |
| View deal → |
